Ligand Pharmaceuticals Inc (LGNZZ) SEC Filings — 2025
17 SEC filings for Ligand Pharmaceuticals Inc (LGNZZ) in 2025.
Filings
- Ligand Pharmaceuticals Files 8-K for Regulation FD Disclosure — 8-K · Dec 18, 2025
- Ligand Pharma Swings to Profit on Soaring Revenue, Strategic Investments — 10-Q · Nov 7, 2025
- Ligand Pharmaceuticals Inc 8-K Filing — 8-K · Nov 6, 2025
- Ligand Pharmaceuticals Enters Material Definitive Agreement — 8-K · Sep 16, 2025
- Ligand Pharma Reports Material Agreement, Financial Obligations — 8-K · Aug 14, 2025
- Ligand Pharmaceuticals Enters Material Definitive Agreement — 8-K · Aug 11, 2025
- Ligand Pharma's Revenue Plunges 40% Amid Royalty and Captisol Declines — 10-Q · Aug 8, 2025
- Ligand Pharmaceuticals Files 8-K on Financials — 8-K · Aug 7, 2025
- Ligand Pharmaceuticals Files 8-K — 8-K · Jul 2, 2025
- Ligand Pharmaceuticals Files 8-K on Shareholder Vote — 8-K · Jun 9, 2025
- Ligand Pharmaceuticals Q1 2025 Update — 10-Q · May 9, 2025
- Ligand Pharmaceuticals Files 8-K on Financials — 8-K · May 8, 2025
- Ligand Pharma Files 2024 Executive Compensation Details — DEF 14A · Apr 22, 2025
- Ligand Pharmaceuticals Files 8-K Current Report — 8-K · Apr 17, 2025
- Ligand Pharmaceuticals Files 2024 Annual Report — 10-K · Feb 28, 2025
- Ligand Pharmaceuticals Files 8-K on Financials — 8-K · Feb 27, 2025
- Ligand Pharmaceuticals Enters Material Definitive Agreement — 8-K · Feb 25, 2025